182 related articles for article (PubMed ID: 15510981)
1. Safety and efficacy of enoxaparin treatment in venous thromboembolic disease during acute leukemia.
Imberti D; Vallisa D; Anselmi E; Moroni CF; Bertè R; Lazzaro A; Bernuzzi P; Arcari AL; Cavanna L
Tumori; 2004; 90(4):390-3. PubMed ID: 15510981
[TBL] [Abstract][Full Text] [Related]
2. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.
Merli G; Spiro TE; Olsson CG; Abildgaard U; Davidson BL; Eldor A; Elias D; Grigg A; Musset D; Rodgers GM; Trowbridge AA; Yusen RD; Zawilska K;
Ann Intern Med; 2001 Feb; 134(3):191-202. PubMed ID: 11177331
[TBL] [Abstract][Full Text] [Related]
4. A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer.
Simonneau G; Laporte S; Mismetti P; Derlon A; Samii K; Samama CM; Bergman JF;
J Thromb Haemost; 2006 Aug; 4(8):1693-700. PubMed ID: 16796710
[TBL] [Abstract][Full Text] [Related]
5. Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
Davidson BL; Büller HR; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob GE; Segers AE; Lensing AW;
J Thromb Haemost; 2007 Jun; 5(6):1191-4. PubMed ID: 17403087
[TBL] [Abstract][Full Text] [Related]
6. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.
Turpie AG; Bauer KA; Eriksson BI; Lassen MR
Arch Intern Med; 2002 Sep; 162(16):1833-40. PubMed ID: 12196081
[TBL] [Abstract][Full Text] [Related]
7. Dabigatran: new drug. Continue to use heparin, a better-known option.
Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
[TBL] [Abstract][Full Text] [Related]
8. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group.
Leclerc JR; Gent M; Hirsh J; Geerts WH; Ginsberg JS
Arch Intern Med; 1998 Apr; 158(8):873-8. PubMed ID: 9570173
[TBL] [Abstract][Full Text] [Related]
9. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.
Büller HR; Davidson BL; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob G; Segers AE; Cariou R; Leeuwenkamp O; Lensing AW;
Ann Intern Med; 2004 Jun; 140(11):867-73. PubMed ID: 15172900
[TBL] [Abstract][Full Text] [Related]
10. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
[TBL] [Abstract][Full Text] [Related]
11. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
Bauer KA; Eriksson BI; Lassen MR; Turpie AG;
N Engl J Med; 2001 Nov; 345(18):1305-10. PubMed ID: 11794149
[TBL] [Abstract][Full Text] [Related]
12. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis.
Superficial Thrombophlebitis Treated By Enoxaparin Study Group
Arch Intern Med; 2003 Jul; 163(14):1657-63. PubMed ID: 12885680
[TBL] [Abstract][Full Text] [Related]
13. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
14. Clinically significant venous thromboembolic complications in burn patients receiving unfractionated heparin or enoxaparin as prophylaxis.
Bushwitz J; LeClaire A; He J; Mozingo D
J Burn Care Res; 2011; 32(6):578-82. PubMed ID: 21841495
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease.
Kleber FX; Witt C; Vogel G; Koppenhagen K; Schomaker U; Flosbach CW;
Am Heart J; 2003 Apr; 145(4):614-21. PubMed ID: 12679756
[TBL] [Abstract][Full Text] [Related]
16. Safety of anticoagulation in thrombocytopenic patients with hematologic malignancies: A case series.
Campbell PM; Ippoliti C; Parmar S
J Oncol Pharm Pract; 2017 Apr; 23(3):220-225. PubMed ID: 26854266
[TBL] [Abstract][Full Text] [Related]
17. Once-Daily Versus Twice-Daily Enoxaparin for the Treatment of Acute Venous Thromboembolism in Cancer Patients.
Fuller K; Malecki S; Anselmo L; Borrego ME; Jakeman B; Burnett A
Ann Pharmacother; 2018 Mar; 52(3):257-262. PubMed ID: 29025276
[TBL] [Abstract][Full Text] [Related]
18. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
Bergmann JF; Neuhart E
Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
[TBL] [Abstract][Full Text] [Related]
19. Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia.
Del Principe MI; Buccisano F; Maurillo L; Venditti D; Cefalo M; Sarlo C; Di Caprio L; Di Veroli A; Nasso D; Ceresoli E; Postorino M; Di Piazza F; Colandrea G; Conti F; Del Poeta G; Amadori S; Venditti A
Thromb Res; 2013 Nov; 132(5):511-4. PubMed ID: 24090605
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center.
Vu K; Luong NV; Hubbard J; Zalpour A; Faderl S; Thomas DA; Yang D; Kantarjian H; Kroll MH
Cancer Med; 2015 Jan; 4(1):27-35. PubMed ID: 25487644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
